Zobrazeno 1 - 10
of 917
pro vyhledávání: '"Larry, Michael"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Florida Bar Journal. Sep2003 Directory, Vol. 77 Issue 8, p234-330. 97p.
Autor:
Bryce B. Reeve, Larry Michael, Joy A. Peter, Paul W. Stewart, Anna S.-F. Lok, Meichen Dong, Ken Bergquist, David R. Nelson, Donna M. Evon
Publikováno v:
GastroHep. 2022:1-9
Background. Despite high efficacy rates for direct acting antiviral regimens to cure hepatitis C virus infection, many patients experience treatment-related symptoms. Accurate reporting of adverse events is mandatory to determine drug safety. Previou
Publikováno v:
Frontiers in Psychology, Vol 10 (2019)
Numerous studies have established the influence of detrimental home conditions on child cognition and behavior; however, fewer have assessed these outcomes in the context of relatively “normal” range of home environmental conditions. Given the ex
Externí odkaz:
https://doaj.org/article/59c9d0113c9f44aa8c6bc493a6e7e2cc
Autor:
Donna M, Evon, Meichen, Dong, Bryce B, Reeve, Joy, Peter, Larry, Michael, Anna S, Lok, David R, Nelson, Paul W, Stewart
Publikováno v:
Journal of Viral Hepatitis. 29:795-806
The PRIORITIZE trial (clinicaltrials.gov: NCT02786537) was the first comparative effectiveness study to directly compare ledipasvir/sofosbuvir (LDV/SOF) and elbasvir/grazoprevir (EBR/GZR) for the treatment of chronic hepatitis C virus (HCV). A second
Publikováno v:
Advocate. 9/9/2008, Issue 1014, p15-15. 1/3p.
Autor:
Joy Peter, Larry Michael, Rakesh Tripathi, Gurjit S. Sidhu, Ryan Tamashiro, Lois Larsen, Gary P. Wang, Jens Kort, David R. Nelson, Gretja Schnell, Joan A. Whitlock, Michael W. Fried, Layla Schuster, Ken Bergquist, Chandni B. Patel, Ashley Magee
Publikováno v:
Journal of Hepatology. 75:820-828
Background & Aims Retreatment with glecaprevir/pibrentasvir (G/P) resulted in a rate of sustained virologic response 12 weeks after treatment completion (SVR12) of >90% in HCV genotype 1 (GT1) patients who previously failed a regimen of sofosbuvir pl
Publikováno v:
In The Journal of Prosthetic Dentistry
Autor:
Larry Michael Over, Eric Dierks
Publikováno v:
The Journal of Prosthetic Dentistry.
This clinical report describes the design and fabrication of an implant-retained and soft-tissue-supported obturator prosthesis and a magnetic retained midfacial prosthesis for a patient with a midfacial defect following bilateral total maxillectomy,
Publikováno v:
In Oral and Maxillofacial Surgery Clinics of North America November 2012 24(4):697-712